CA2248955A1 — The use of fumaric acid derivatives
Assigned to Biogen International GmbH · Expires 1997-05-20 · 29y expired
What this patent protects
The present invention relates to the use of certain fumaric acid monoalkyl esters as salts or free acids thereof either alone or in combination with a dialkyl fumarate for preparing pharmaceutical compositions for the treatment of auto-immune diseases.
USPTO Abstract
The present invention relates to the use of certain fumaric acid monoalkyl esters as salts or free acids thereof either alone or in combination with a dialkyl fumarate for preparing pharmaceutical compositions for the treatment of auto-immune diseases.
Drugs covered by this patent
- Tecfidera (DIMETHYL FUMARATE) · Biogen
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.